Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

11 November 2024

SEED Innovations Limited

("SEED" or the "Company")

Divested interest in Pantheon Resources to secure profit of c.35% in three months

Creating value from opportunistic short-term trading strategy

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to announce that it has exited its entire position in AIM listed Pantheon Resources plc ("Pantheon") at an average price of 22.91p per share for gross proceeds of £336,918.90.

HIGHLIGHTS

·    Gross proceeds of approximately £337,000

·    Divestment represents a profit of £86,918.94

·    Profit of nearly 35% / 6p per Pantheon share in a three-month period

Commenting on the divestment, SEED CEO Ed McDermott said: "I am delighted with the outcome of this transaction, which highlights our agility in capturing short-term trading opportunities that drive value for our shareholders. This divestment in Pantheon generated gross proceeds of approximately £337,000, delivering a profit of c. £87,000, or nearly 35%, in just three months. Our strong cash position of £3.8Million continues to both exceed our current market capitalisation (by over 30%) and provide the flexibility needed to capitalise on similar prospects, and as such we anticipate taking advantage of other similar opportunities in the future."

DETAILS

In August 2024, SEED invested £250,000 in AIM listed oil and gas company Pantheon (see RNS dated 7 August) at a price of £0.17 (17p per share) paid for from cash reserves. It has now exited its entire position in Pantheon at an average price of 22.91p per share for gross proceeds of £336,918.90. This represents a profit of £86,918.94, or nearly 35% / 6p per Pantheon share in a three month period.

- Ends -

For further information visit: www.seedinnovations.co or contact:

Notes

Seed Innovations Ltd is an AIM quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the company is agile and poised to capitalise swiftly on new investment opportunities.

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.